Bioorganic and Medicinal Chemistry Letters

Accessible 5'-end of CpG-containing Phosphorothioate Oligodeoxynucleotides is essential for immunostimulatory activity
pp. 2585-2588(4)
Authors: Yu D.; Zhao Q.; Kandimalla E.R.; Agrawal S.

Synthesis and antiproliferative activity of Benzocyclobutacarbazol derivatives. A new class of potential antitumor agents
pp. 2589-2591(3)
Authors: Graf-Christophe S.; Kuehm-Caubere C.; Renard P.; Pfeiffer B.; Pierre A.; Leonce S.; Caubere P.

DNA minor groove interactions and the biological activity of 2,5-bis-[4-(N-alkylamidino)phenyl] furans
pp. 2593-2597(5)
Authors: Simpson I.J.; Lee M.; Kumar A.; Boykin D.W.; Neidle S.

2,4,5-Trisubstituted imidazoles - novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 1¹
pp. 2599-2601(3)
Authors: Sarshar S.; Zhang C.; Moran E.J.; Krane S.; Rodarte J.C.; Benbatoul K.D.; Dixon R.; Mjalli A.M.M.

2,4,5-Trisubstituted imidazoles - novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 2¹
pp. 2603-2605(3)
Authors: Zhang C.; Sarshar S.; Moran E.J.; Krane S.; Rodarte J.C.; Benbatoul K.D.; Dixon R.; Mjalli A.M.M.

Improved synthesis of the iodine-free thyromimetic GC-1
pp. 2607-2611(5)
Authors: Chiellini G.; Nguyen N.-H.; Yoshihara H.A.I.; Scanlan T.S.

Fatty acid amide hydrolase substrate specificity
pp. 2613-2616(4)
Authors: Boger D.L.; Fecik R.A.; Patterson J.E.; Miyauchi H.; Patricelli M.P.; Cravatt B.F.

Highly specific inhibitory effect of three-component hybrid liposomes including sugar surfactants on the growth of glioma cells
pp. 2617-2619(3)
Authors: Matsumoto Y.; Kato T.; Suzuki H.; Hirose S.; Naiki Y.; Hirashima M.; Ueoka R.

Aminoanthraquinones as novel ligands at the polyamine binding site on the N-methyl-d-aspartate receptor complex
pp. 2621-2623(3)
Authors: Bence A.K.; Rogers D.T.; Worthen D.R.; Fu M.; Littleton J.M.; Crooks P.A.

6-Hydroxy-1,3-dioxin-4-ones as non-peptidic HIV protease inhibitors
pp. 2625-2627(3)
Authors: Lee Y.S.; Lee Y.S.; Lee J.Y.; Kim S.N.; Lee C.-K.; Park H.

New multidrug resistance modulators from atractylodis lanceae rhizoma
pp. 2629-2632(4)
Authors: Murakami N.; Iwata E.; Tamura S.; Akiyama S.; Kobayashi M.

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes
pp. 2633-2637(5)
Authors: Tamamura H.; Omagari A.; Oishi S.; Kanamoto T.; Yamamoto N.; Peiper S.C.; Nakashima H.; Otaka A.; Fujii N.

Synthesis of a statistically exhaustive fluorescent peptide substrate library for profiling protease specificity
pp. 2639-2642(4)
Authors: Sheppeck II J.E.; Kar H.; Gosink L.; Wheatley J.B.; Gjerstad E.; Loftus S.M.; Zubiria A.R.; Janc J.W.

Serotonin transporter inhibitors: synthesis and binding potency of 2'-methyl- and 3'-methyl-6-nitroquipazine
pp. 2643-2646(4)
Authors: Gerdes J.M.; DeFina S.C.; Wilson P.A.; Taylor S.E.

(S)-Thiirancarboxylic acid as a reactive building block for a new class of cysteine protease inhibitors
pp. 2647-2651(5)
Author: Schirmeister T.

In vitro selection of hematoporphyrin binding DNA aptamers
pp. 2653-2656(4)
Authors: Okazawa A.; Maeda H.; Fukusaki E.; Katakura Y.; Kobayashi A.

Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2-[(4-methylthiopyridin-2-yl)methylsulfinyl]benzimidazole
pp. 2657-2660(4)
Authors: Hamaguchi T.; Takahashi A.; Kagamizono T.; Manaka A.; Sato^a M.; Osada H.

Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties
pp. 2661-2664(4)
Authors: Crespo M.I.; Gracia J.; Puig C.; Vega A.; Bou J.; Beleta J.; Domenech T.; Ryder H.; Segarra V.; Palacios J.M.

Chain-lengthened and imidazoline analogues of nicotine
pp. 2665-2668(4)
Authors: Ferretti G.; Dukat M.; Giannella M.; Piergentili A.; Pigini M.; Quaglia W.; Damaj M.I.; Martin B.R.; Glennon R.A.

Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells
pp. 2669-2673(5)
Authors: Simoni D.; Roberti M.; Paolo Invidiata F.; Rondanin R.; Baruchello R.; Malagutti C.; Mazzali A.; Rossi M.; Grimaudo S.; Dusonchet L.; Meli M.; Raimondi M.V.; D'Alessandro N.; Tolomeo M.

Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives
pp. 2675-2678(4)
Authors: Hoemann M.Z.; Kumaravel G.; Xie R.L.; Rossi R.F.; Meyer S.; Sidhu A.; Cuny G.D.; Hauske J.R.

Total synthesis of mololipids: A new series of anti-HIV Moloka'iamine derivatives
pp. 2679-2681(3)
Authors: Schoenfeld R.C.; Lumb J.-P.; Fantini J.; Ganem B.

Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx^&unknown;)
pp. 2683-2686(4)
Authors: Nicoll-Griffith D.A.; Yergey J.A.; Trimble L.A.; Silva J.M.; Li C.; Chauret N.; Gauthier J.Y.; Grimm E.; Leger S.; Roy P.; Therien M.; Wang Z.; Prasit P.; Zamboni R.; Young R.N.; Brideau C.; Chan C.-C.; Mancini J.; Riendeau D.

Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication
pp. 2687-2690(4)
Authors: Perni R.B.; Conway^&unknown; S.C.; Ladner^&unknown; S.K.; Zaifert^&unknown; K.; Otto^&unknown; M.J.; King^&unknown; R.W.

Corrigendum to ''Design and synthesis of functionalized glycomers as non-peptidic ligands for SH2 binding and as inhibitors of A-431 human epidermoid and HT-29 colon carcinoma cell lines'' [Bioorg. Med. Chem. Lett. 10 (2000) 439]^&unknown;
pp. 2691-2691(1)
Authors: Hanessian S.; Saavedra O.M.; Xie F.; Amboldi N.; Battistini C.